Education
About Us
Working with TipRanks
Follow Us
Hangzhou Tigermed Consulting Co., Ltd. Class H (HK:3347)
:3347
Total Valuation
Hangzhou Tigermed Consulting Co., Ltd. Class H has a market cap or net worth of HK$49.58B. The enterprise value is HK$36.84B.
Market CapHK$49.58B
Enterprise ValueHK$36.84B
Share Statistics
Hangzhou Tigermed Consulting Co., Ltd. Class H has 123,124,800 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding123,124,800
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Hangzhou Tigermed Consulting Co., Ltd. Class H’s return on equity (ROE) is 0.02 and return on invested capital (ROIC) is 1.66%.
Return on Equity (ROE)0.02
Return on Assets (ROA)0.01
Return on Invested Capital (ROIC)1.66%
Return on Capital Employed (ROCE)0.03
Revenue Per Employee648.32K
Profits Per Employee43.97K
Employee Count10,185
Asset Turnover0.23
Inventory Turnover136.47
Valuation Ratios
The current PE Ratio of Hangzhou Tigermed Consulting Co., Ltd. Class H is 125.4. Hangzhou Tigermed Consulting Co., Ltd. Class H’s PEG ratio is -0.77.
PE Ratio125.4
PS Ratio3.79
PB Ratio1.21
Price to Fair Value1.21
Price to FCF33.79
Price to Operating Cash Flow38.07
PEG Ratio-0.77
Income Statement
In the last 12 months, Hangzhou Tigermed Consulting Co., Ltd. Class H had revenue of 6.60B and earned 405.14M in profits. Earnings per share was 0.47.
Revenue6.60B
Gross Profit2.24B
Operating Income664.42M
Pretax Income664.46M
Net Income405.14M
EBITDA1.13B
Earnings Per Share (EPS)0.47
Cash Flow
In the last 12 months, operating cash flow was 408.62M and capital expenditures -48.09M, giving a free cash flow of 747.53M billion.
Operating Cash Flow408.62M
Free Cash Flow747.53M
Free Cash Flow per Share6.07
Dividends & Yields
Hangzhou Tigermed Consulting Co., Ltd. Class H pays an annual dividend of HK$0.325, resulting in a dividend yield of 0.75%
Dividend Per ShareHK$0.325
Dividend Yield0.75%
Payout Ratio85.85%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.87
52-Week Price Change8.82%
50-Day Moving Average50.27
200-Day Moving Average37.64
Relative Strength Index (RSI)39.06
Average Volume (3m)2.81M
Important Dates
Hangzhou Tigermed Consulting Co., Ltd. Class H upcoming earnings date is Oct 29, 2025, TBA (Not Confirmed).
Last Earnings DateAug 29, 2025
Next Earnings DateOct 29, 2025
Ex-Dividend DateJun 12, 2025
Financial Position
Hangzhou Tigermed Consulting Co., Ltd. Class H as a current ratio of 1.72, with Debt / Equity ratio of 11.60%
Current Ratio1.72
Quick Ratio1.71
Debt to Market Cap0.09
Net Debt to EBITDA0.51
Interest Coverage Ratio4.70
Taxes
In the past 12 months, Hangzhou Tigermed Consulting Co., Ltd. Class H has paid 216.63M in taxes.
Income Tax216.63M
Effective Tax Rate0.33
Enterprise Valuation
Hangzhou Tigermed Consulting Co., Ltd. Class H EV to EBITDA ratio is 22.66, with an EV/FCF ratio of 34.57.
EV to Sales3.88
EV to EBITDA22.66
EV to Free Cash Flow34.57
EV to Operating Cash Flow23.34
Balance Sheet
Hangzhou Tigermed Consulting Co., Ltd. Class H has HK$1.82B in cash and marketable securities with HK$2.38B in debt, giving a net cash position of -HK$561.43M billion.
Cash & Marketable SecuritiesHK$1.82B
Total DebtHK$2.38B
Net Cash-HK$561.43M
Net Cash Per Share-HK$4.56
Tangible Book Value Per ShareHK$23.70
Margins
Gross margin is 29.05%, with operating margin of 10.06%, and net profit margin of 6.14%.
Gross Margin29.05%
Operating Margin10.06%
Pretax Margin10.06%
Net Profit Margin6.14%
EBITDA Margin17.11%
EBIT Margin12.20%
Analyst Forecast
The average price target for Hangzhou Tigermed Consulting Co., Ltd. Class H is HK$53.57, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price TargetHK$53.57
Price Target Upside24.05% Upside
Analyst ConsensusModerate Buy
Analyst Count5
Revenue Growth Forecast-7.82%
EPS Growth Forecast-73.16%